LEO Pharma (Rights of PDE4 Inhibitor Series)

Business Data, Corporate Office and Headquarter Address

About

LEO Pharma (Rights of PDE4 Inhibitor Series) is Buildings and Property in Denmark that focus on Ballerup business. They cover business area such as Ballerup.

Business Type

Buildings and Property

Country

Denmark

Founded

-

Company Focus

Ballerup

Website

-

Corporate Office and Headquarter Office address:

Industriparken 55
2750 Ballerup
Denmark

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

Ballerup

* We use standard office opening hours in near LEO Pharma (Rights of PDE4 Inhibitor Series)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

LEO Pharma (Rights of PDE4 Inhibitor Series) Frequently Asked Questions

What or who is LEO Pharma (Rights of PDE4 Inhibitor Series)?

LEO Pharma (Rights Of PDE4 Inhibitor Series) is Buildings and Property business from Denmark that founded in - ( years old in ), LEO Pharma (Rights of PDE4 Inhibitor Series) business is focusing on Ballerup.

Where is LEO Pharma (Rights of PDE4 Inhibitor Series) headquarter and corporate office address?

LEO Pharma (Rights of PDE4 Inhibitor Series) headquarter office and corporate office address is located in Industriparken 55 2750 Ballerup Denmark.

Where is LEO Pharma (Rights of PDE4 Inhibitor Series) country origins?

LEO Pharma (Rights of PDE4 Inhibitor Series) was founded in Denmark.

What is Ballerup business focus on?

In , LEO Pharma (Rights of PDE4 Inhibitor Series) is currently focus on Ballerup sector.

Ballerup Business Interest from Google Trend

Above is snippet of Google Trends for "Ballerup" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with LEO Pharma (Rights of PDE4 Inhibitor Series), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.